iSpecimen Inc. (ISPC): Price and Financial Metrics
GET POWR RATINGS... FREE!
ISPC Stock Price Chart Interactive Chart >
ISPC Price/Volume Stats
|Current price||$2.89||52-week high||$28.98|
|Prev. close||$2.90||52-week low||$2.07|
|Day high||$2.95||Avg. volume||731,589|
|50-day MA||$3.49||Dividend yield||N/A|
|200-day MA||$6.09||Market Cap||25.48M|
iSpecimen Inc. (ISPC) Company Bio
iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Most Popular Stories View All
ISPC Latest News Stream
|Loading, please wait...|
ISPC Latest Social Stream
View Full ISPC Social Stream
Latest ISPC News From Around the Web
Below are the latest news stories about iSpecimen Inc that investors may wish to consider to help them evaluate ISPC as an investment opportunity.
Quite a few insiders invested in iSpecimen Inc. (NASDAQ:ISPC) last year which is positive news for shareholders
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Gainers: Aridis Pharmaceuticals (NASDAQ:ARDS) +12%. Rhythm Pharmaceuticals (NASDAQ:RYTM) +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen (NASDAQ:ISPC) -10%. Poseida Therapeutics (NASDAQ:PSTX) -8%. R1 RCM (NASDAQ:RCM) -8%. Community Health Systems (NYSE:CYH) -6%....
Call Ended: 08:53 Title: iSpecimen Inc. (ISPC) Q4 2021 Earning Conference Call February 17, 2022, 8:30 AM ET Company Participants Christopher Ianelli – Chief Executive Officer and President Tracy Curley – Chief Financial Officer Jill Mullan – Chief Operating Officer Allison Soss – Investor Relations Conference Call Participants Lucas Baranowski...
Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36%LEXINGTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today reported its financial results for the three and twelve-month periods ended December 31, 2021. “iSpecimen achieved significant milestones in 2021. During the year, we successfully closed our IPO and began trading on the NASDAQ, raised $21 milli
LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022. Dr. Ianelli will present on Thursday, February 24, 2022 at 12:30 p.m. ET. To access the event, please download and import the following iCalendar (.ics) files to
ISPC Price Returns